Sage Capital Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2030667
Stockton, NJ
Position in VRTX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$234,456
+$23,690 QoQ
Shares Held
472
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#1,345
of 1,735 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sage Capital Management, LLC holds $320,925 across 2 Biotechnology names. VRTX ranks #1 (73.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
472 | $234,456 | |
| 2 | ORMP |
Oramed Pharmaceuticals Inc.
|
17,977 | $86,469 |
All Filings in VRTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $234,456 | 472 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $210,766 | 472 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $213,985 | 472 | Shares | Sole | 2026-01-15 | |
| 2025-06-30 | $210,134 | 472 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $228,835 | 472 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $219,517 | 472 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $221,235 | 472 | Shares | Sole | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||